Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Taiho Oncology, Inc.
U.S. FDA Approves INQOVI® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
May 13, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
April 28, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
Tickers
CGEM
Taiho Oncology Appoints Peter Melnyk as President & Chief Executive Officer
January 28, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
Peter Melnyk Joins Taiho Oncology as President & Chief Operating Officer
January 20, 2026
From
Taiho Oncology, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.